NCT03578367 2025-11-10Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)NovartisPhase 2 Completed104 enrolled 11 charts
NCT01760655 2025-10-30Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic MalignanciesThomas Jefferson UniversityPhase 2 Completed62 enrolled 15 charts
NCT03066648 2025-05-18Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDSNovartisPhase 1 Completed241 enrolled
NCT05458258 2025-04-30Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid LeukemiaUniversity of ChicagoCompleted239 enrolled
NCT04628338 2025-04-29IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationUniversity of PittsburghPhase EARLY_PHASE1 Completed8 enrolled
NCT06904859 2025-04-01The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid LeukemiaShenzhen University General HospitalPhase EARLY_PHASE1 Completed50 enrolled
NCT05282459 2025-03-20Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 MutationStanford UniversityPhase 1/2 Completed17 enrolled